Switch to: References

Add citations

You must login to add citations.
  1. Is it Really All about the Money? Reconsidering Non-Financial Interests in Medical Research.Richard S. Saver - 2012 - Journal of Law, Medicine and Ethics 40 (3):467-481.
    Conflicts of interest have been reduced to financial conflicts. The National Institutes of Health’s (NIH) new rules for managing conflicts of interest in medical research, the first major change to the regulations in over 15 years, address only financial ties. Although several commentators urged that the regulations also cover non-financial interests, the Department of Health and Human Services declined to do so. Similarly, the Institute of Medicine’s (IOM) influential 2009 Conflict of Interest Report focuses almost exclusively on financial conflicts. Institutional (...)
    Download  
     
    Export citation  
     
    Bookmark   14 citations  
  • Is it Really All about the Money? Reconsidering Non-Financial Interests in Medical Research.Richard S. Saver - 2012 - Journal of Law, Medicine and Ethics 40 (3):467-481.
    Conflicts of interest have been reduced to financial conflicts. The National Institutes of Health’s new rules for managing conflicts of interest in medical research, the first major change to the regulations in over 15 years, address only financial ties. Although several commentators urged that the regulations also cover non-financial interests, the Department of Health and Human Services declined to do so. Similarly, the Institute of Medicine’s influential 2009 Conflict of Interest Report focuses almost exclusively on financial conflicts. Institutional policies at (...)
    Download  
     
    Export citation  
     
    Bookmark   14 citations  
  • Systematic review: bioethical implications for COVID-19 research in low prevalence countries, a distinctly different set of problems.Rohan Rodricks, Constance Law & Tony Skapetis - 2021 - BMC Medical Ethics 22 (1):1-8.
    BackgroundThe COVID-19 pandemic has presented extraordinary challenges to worldwide healthcare systems, however, prevalence remains low in some countries. While the challenges of conducting research in high-prevalence countries are well published, there is a paucity from low COVID-19 countries.MethodsA PRISMA guided systematic review was conducted using the databases Ovid-Medline, Embase, Scopus and Web of Science to identify relevant articles discussing ethical issues relating to research in low prevalence COVID-19 countries.ResultsThe search yielded 133 original articles of which only 2 fit the inclusion (...)
    Download  
     
    Export citation  
     
    Bookmark